Eagle Harbor Asset Management’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-4,000
Closed -$348K – 143
2026
Q2
$348K Buy
+4,000
New +$242K 0.27% 101

Other funds holding CORT

Eagle Harbor Asset Management's CORT Position: Q3 2026 in Review

Eagle Harbor Asset Management sold out of Corcept Therapeutics (CORT) in Q3 2026, closing a stake of 4,000 shares — an estimated $348K sold.

Eagle Harbor Asset Management first reported a position in CORT in Q2 2026 and held it in 1 quarter. The position peaked at $348K in Q2 2026. 503 funds tracked by Wall St. Rank hold CORT as of Q3 2026.

  • Eagle Harbor Asset Management reported no remaining Corcept Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Eagle Harbor Asset Management sold 4,000 Corcept Therapeutics shares in Q3 2026, an estimated $348K.
  • Eagle Harbor Asset Management first reported a position in Corcept Therapeutics in Q2 2026 and held it in 1 quarter.
  • Eagle Harbor Asset Management's Corcept Therapeutics position peaked at $348K in Q2 2026.
  • 503 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.

Based on Eagle Harbor Asset Management's 13F filing for Q3 2026, filed 21 Oct 2026.